Sun Pharma Recalls 1 Lot of Metformin Due to NDMA Levels

September 28th 2020

Sun Pharmaceuticals issued a voluntary recall of 1 lot of its metformin hydrochloride for extended-release (ER) oral suspension (Riomet ER), 500 mg per 5 mL.

Top 5 drugs in the pipeline

September 22nd 2020

Some of the top medications were approved this summer, while others are awaiting FDA approval.

Major thyroid med recall underway

September 22nd 2020

Both recalls are due to sub-potency of drugs that treat hypothyroidism.

Jardiance to get new heart attack prevention indication

September 15th 2020

The top-selling diabetes drug will join semaglutide (Ozempic), which is approved to reduce the risk of major adverse cardiovascular events.

Carcinoma med snags Breakthrough Therapy Designation

September 14th 2020

The treatment is the first anti-PD-1 antibody from China to receive Breakthrough therapy designation.

Lung cancer's new drug based on precision medicine

September 08, 2020

Pharma makers expect the treatment to be available within a week.

FDA clears oral leukemia drug

September 08, 2020

The medication boasts a statistically significant improvement in overall survival versus placebo.

FDA expands emergency use authorization for remdesivir to include all hospitalized COVID-19 patients

August 31, 2020

One study questions the effectiveness of remdesivir past day 10 while others support its expanded use.

U.S. gov’t, Abbot team up to produce millions of rapid COVID-19 tests

August 28, 2020

The pharma maker will initially produce 150 million of the 5-minute tests.

FDA clears 2 therapies for rare conditions

August 18, 2020

Drug for a specific Duchenne muscular dystrophy mutation is only the second drug approved for the mutation.

Investigational lymphoma treatment gets FDA nod

August 17, 2020

The drug’s indication for marginal zone lymphoma (MZL) may not be approved until February 2021.

FDA clears first oral drug to treat spinal muscular atrophy

August 11, 2020

Evrysdi is only the second drug approved to treat the rare disease.

Novel IV opioid will be available this year

August 11, 2020

Olinvyk is the first new chemical entity in this IV drug class in decades.

FDA clears first cell-based gene therapy for lymphoma

August 04, 2020

The chimeric antigen receptor (CAR) T cell therapy is the first of its kind for mantle cell lymphoma (MCL).

Controversial depression nasal spray snares new indication

August 04, 2020

Esketamine (Spravato) can now be used to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

FDA clears novel psoriatic arthritis treatment

July 21, 2020

The drug is the first treatment approved for active psoriatic arthritis that selectively inhibits interleukin (IL)-23.

Express Scripts accused of overcharging millions of dollars

July 21, 2020

The PBM overcharged for generic drugs, among other offenses, a new lawsuit claims.

Sandoz to supply critical generic injectable meds

July 14, 2020

The pharma maker is partnering with the nonprofit Civica Rx to help reduce shortages in hospitals.

Another pharma maker recalls metformin over NDMA

July 13, 2020

Five other manufacturers have recalled the popular diabetes medication due to the presence of a the carcinogenic ingredient.

Popular HIV-1 med successful, particularly in order adults

July 07, 2020

Gilead will present new data on virologic suppression in adults 65 years and older at AIDS 2020: Virtual this week.

FDA clears first-in-class HIV-1 treatment

July 06, 2020

Drug helps with heavily-treatment experienced (HTE) adults with multidrug-resistant HIV-1 infection.

U.S. government secures remdesivir supply for COVID-19 patients

June 30, 2020

Price of the drug to treat hospitalized patients revealed.

FDA okays novel breast, colorectal cancer treatments

June 30, 2020

Colorectal cancer drug is the first immunotherapy administered as a first-line treatment and without chemotherapy.

Top 3 drugs to watch in second half 2020

June 23, 2020

These are the top 3 drugs recently approved — or soon to be approved by FDA — to watch in 2020.

Pharma maker seeks fast approval of lymphoma treatment

June 23, 2020

Investigational treatment will target marginal zone lymphoma (MZL) and follicular lymphoma (FL).

FDA pulls hydroxychloroquine for COVID-19, warns about other drug interaction

June 16, 2020

The agency revoked its emergency use authorization (EUA) for the drug, while warning about a dangerous interaction with remdesivir.

New pediatric HIV med available

June 15, 2020

The unique formulation is a dispersible tablet for children.

Major Metformin recalls underway

June 08, 2020

Five pharma markers are recalling the diabetes medication due to the presence of a carcinogenic ingredient.

Remdesivir for COVID-19 in short supply

June 08, 2020

HHS says supply could run out by the end of this month.

New antibiotic for hospital-acquired pneumonia available

June 05, 2020

The agency welcomes another option for serious bacterial infections.